Comparison of Patient Outcomes With Two Different Formulations of Melphalan as Conditioning Chemotherapy for Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. uri icon

authors

  • Khan, Abdullah M
  • Efebera, Yvonne
  • Devarakonda, Srinivas
  • Yucebay, Filiz
  • Zhao, Qiuhong
  • Umyarova, Elvira
  • Cottini, Francesca
  • Bumma, Naresh
  • Ashley E. Rosko, MD
  • Benson, Don
  • Sharma, Nidhi

publication date

  • October 27, 2022